These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14650203)

  • 1. [Endothelium derived relaxing factor and its effect on vascular disease].
    Wang J; Li Z
    Wei Sheng Yan Jiu; 2003 Sep; 32(5):508-10. PubMed ID: 14650203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to EDRF research.
    Furchgott RF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelium-derived relaxing factor/nitrogen oxide. Pharmacological and clinical cardiovascular aspects].
    Laursen JB; Boesgaard S; Poulsen HE; Aldershvile J
    Ugeskr Laeger; 1994 Sep; 156(39):5661-6. PubMed ID: 7985247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion.
    Lüscher TF; Yang ZH; Diederich D; Bühler FR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S63-9. PubMed ID: 2478827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EDRF/NO and endothelial functions].
    Delonca J; Balteaux V; Giraud T; Sanchez RY
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1617-24. PubMed ID: 8010861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of EDRF and EDHF to restoration of endothelial function following dietary restrictions in hypercholesterolemic rats.
    Ashraf MZ; Reddy MK; Hussain ME; Podrez EA; Fahim M
    Indian J Exp Biol; 2007 Jun; 45(6):505-14. PubMed ID: 17585684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact and altered endothelium in regulation of vasomotion.
    Lerman A; Burnett JC
    Circulation; 1992 Dec; 86(6 Suppl):III12-19. PubMed ID: 1424046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nitric oxide and circulatory homeostasis].
    Arnal JF
    Ann Cardiol Angeiol (Paris); 1997; 46(7):420-5. PubMed ID: 9452776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ouabain on the vasodilator actions of nitric oxide and S-nitrosothiols in vivo: relevance to the identity of EDRF/EDHF.
    Lewis SJ; Travis MD; Hashmi-Hill MP; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Dec; 45(6):383-94. PubMed ID: 16861050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO: the primary EDRF.
    Fleming I; Busse R
    J Mol Cell Cardiol; 1999 Jan; 31(1):5-14. PubMed ID: 10072711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction and vascular pathology].
    Vanhoutte PM
    Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EDRF-NO. The endothelium-derived relaxing factor is nitric oxide].
    Schreiber V
    Cas Lek Cesk; 1992 Jul; 131(13):388-90. PubMed ID: 1504992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries.
    Boer C; Groeneveld AB; Scheffer GJ; de Lange JJ; Westerhof N; Sipkema P
    J Surg Res; 2005 Aug; 127(2):197-202. PubMed ID: 15921694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of sickle cells to scavenge endothelium-derived nitric oxide is reduced.
    Olmos L; Mombouli JV; Wasserstrum N; Vanhoutte PM
    Acta Pharmacol Sin; 2002 Nov; 23(11):967-73. PubMed ID: 12421471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen modulation of endothelium-derived relaxing factors by human endothelial cells.
    Rahimian R; Chan L; Goel A; Poburko D; van Breemen C
    Biochem Biophys Res Commun; 2004 Sep; 322(2):373-9. PubMed ID: 15325240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (Açaí) extracts in mesenteric vascular bed of the rat.
    Rocha AP; Carvalho LC; Sousa MA; Madeira SV; Sousa PJ; Tano T; Schini-Kerth VB; Resende AC; Soares de Moura R
    Vascul Pharmacol; 2007 Feb; 46(2):97-104. PubMed ID: 17049314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.